These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 2474373

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Sister chromatid exchanges, chromosomal aberrations, and cytotoxicity produced by antitumor topoisomerase II inhibitors in sensitive (DC3F) and resistant (DC3F/9-OHE) Chinese hamster cells.
    Pommier Y, Kerrigan D, Covey JM, Kao-Shan CS, Whang-Peng J.
    Cancer Res; 1988 Feb 01; 48(3):512-6. PubMed ID: 2825977
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Differentiation of human promonocytic leukemia U-937 cells with DNA topoisomerase II inhibitors: induction of vimentin gene expression.
    Rius C, Zorrilla AR, Cabañas C, Mata F, Bernabeu C, Aller P.
    Mol Pharmacol; 1991 Apr 01; 39(4):442-8. PubMed ID: 1850089
    [Abstract] [Full Text] [Related]

  • 6. [Effect of etoposide and amsacrine on mitotic progression of GM-130 and Hep-2 cell lines. The flow cytometry assay].
    Shatrova AN, Aksenov ND, Poletaev AI, Zenin VV.
    Tsitologiia; 2003 Apr 01; 45(1):59-68. PubMed ID: 12683237
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Amsacrine-induced lesions in DNA and their modulation by novobiocin and 2,4-dinitrophenol.
    Shibuya ML, Buddenbaum WE, Don AL, Utsumi H, Suciu D, Kosaka T, Elkind MM.
    Cancer Res; 1991 Jan 15; 51(2):573-80. PubMed ID: 1985775
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of phorbol ester treatment on drug-induced, topoisomerase II-mediated DNA cleavage in human leukemia cells.
    Zwelling LA, Chan D, Hinds M, Mayes J, Silberman LE, Blick M.
    Cancer Res; 1988 Dec 01; 48(23):6625-33. PubMed ID: 2846155
    [Abstract] [Full Text] [Related]

  • 14. Topoisomerase II-mediated DNA breaks and cytotoxicity in relation to cell proliferation and the cell cycle in NIH 3T3 fibroblasts and L1210 leukemia cells.
    Markovits J, Pommier Y, Kerrigan D, Covey JM, Tilchen EJ, Kohn KW.
    Cancer Res; 1987 Apr 15; 47(8):2050-5. PubMed ID: 3030540
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparative effects of growth inhibitors on DNA replication, DNA repair, and protein synthesis in human epidermal keratinocytes.
    Bohr V, Mansbridge J, Hanawalt P.
    Cancer Res; 1986 Jun 15; 46(6):2929-35. PubMed ID: 2421888
    [Abstract] [Full Text] [Related]

  • 17. Effect of topoisomerase II inhibitors on hyperthermic cytotoxicity.
    Warters RL, Brizgys LM.
    Cancer Res; 1988 Jul 15; 48(14):3932-8. PubMed ID: 2838165
    [Abstract] [Full Text] [Related]

  • 18. Effect of polyamine depletion by alpha-difluoromethylornithine or (2R,5R)-6-heptyne-2,5-diamine on drug-induced topoisomerase II-mediated DNA cleavage and cytotoxicity in human and murine leukemia cells.
    Bakic M, Chan D, Freireich EJ, Marton LJ, Zwelling LA.
    Cancer Res; 1987 Dec 15; 47(24 Pt 1):6437-43. PubMed ID: 2824033
    [Abstract] [Full Text] [Related]

  • 19. Estrogen-induced potentiation of DNA damage and cytotoxicity in human breast cancer cells treated with topoisomerase II-interactive antitumor drugs.
    Epstein RJ, Smith PJ.
    Cancer Res; 1988 Jan 15; 48(2):297-303. PubMed ID: 2825970
    [Abstract] [Full Text] [Related]

  • 20. Role of topoisomerase II beta in the resistance of 9-OH-ellipticine-resistant Chinese hamster fibroblasts to topoisomerase II inhibitors.
    Dereuddre S, Delaporte C, Jacquemin-Sablon A.
    Cancer Res; 1997 Oct 01; 57(19):4301-8. PubMed ID: 9331091
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.